Loading clinical trials...
Loading clinical trials...
Early Identification of Patients With Coexisting Atrial Fibrillation and Obstructive Sleep Apnea
The purpose of this research study is to learn about arrhythmia detection in obstructive sleep apnea (OSA). For several years patients with OSA have an increased likelihood of having irregular heartbeats. This study will determine how often patients with OSA have irregular heartbeats. This study will also define which OSA patients are most likely to have irregular heartbeats. The participant is being asked to be in the study because the participant has been diagnosed with obstructive sleep apnea (OSA).
Age
40 - 85 years
Sex
ALL
Healthy Volunteers
No
University of Miami
Miami, Florida, United States
Start Date
March 6, 2017
Primary Completion Date
April 3, 2019
Completion Date
April 3, 2019
Last Updated
November 19, 2020
86
ACTUAL participants
The Lifestar Act III
DEVICE
Lead Sponsor
University of Miami
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05963698